It is a pan-European collaboration that brings together large biopharmaceutical companies, small- and medium-sized enterprises (SMEs), patient organisations, academia, hospitals and public authorities. In 2010 the pharmaceutical industry invested about €27,800 million in R&D in Europe. Education & training: this closes existing training gaps in the drug development process. EFPIA Code of Practice and relationships with patient organisations and healthcare professionals. Welcome to 19 Conversations. The European Federation of Pharmaceutical Industries and Associations or EFPIA is the organization representing the research-based pharmaceutical industry operating in Europe. The geographical balance of the pharmaceutical market – and ultimately the R&D base – is likely to shift gradually towards emerging economies. Vaccines Europe, is a specialised vaccines group within the European Federation of Pharmaceutical Industries and Associations (EFPIA), the professional association of the innovative pharmaceutical industry in Europe. By the time a medicinal product reaches the market, an average of 12–13 years will have elapsed since the first synthesis of the new active substance; The cost of researching and developing a new chemical or biological entity was estimated at €1,059 million ($1,318 million in year 2005 dollars) in 2005 (Di Masi J., Tufts University, Centre for the Study of Drug Development, 2007); On average, only one or two of every 10,000 substances synthesised in laboratories, will successfully pass all the stages to become marketable medicines. Our work is focusing on three areas. The United States still dominates the biopharmaceutical field, accounting for the three quarters of the world's biotechnology revenues and R&D spending. A joint report by the European Animal Research Association (EARA) and the European Federation of Pharmaceutical Industries and Associations has challenged an EU expert group recommendation that calls for an end to the use of animals in antibody research, including Covid-19. EFPIA stands for European Federation of Pharmaceutical Industries Association (also European Federation of Pharmaceutical Industries and Associations and 13 more ) Rating: 1 The key contribution of the research-based pharmaceutical industry to medical progress is to turn fundamental research into High blood pressure and cardiovascular disease can be controlled with anti-hypertensive medicines and cholesterol-lowering medicines, knee or hip replacements prevent patients from immobility, and some cancers can be controlled or even cured thanks to newer targeted medicines. The European Commission and EFPIA have jointly established a new-non-profit European Community body. Predicting safety: this addresses bottlenecks related to accurately evaluating the safety of a compound during the pre-clinical phase of the development process, but also impacts the later phases in clinical development. This page was last edited on 11 December 2020, at 21:18. European Federation of Pharmaceutical Industries and Associations (EFPIA) – POLITICO European Federation of Pharmaceutical Industries and Associations (EFPIA) 38526121292-88. Description of the Initiative - between January 1st 2015 and today (22nd of March 2019), - including briefings, reports, correspondence (email or other), including all attachments to the said correspondance, - a list of all meetings, as well as agendas and minutes or any other reports of such meetings, - from, to, or mentioning, the European Federation of Pharmaceutical Industries and Associations (EFPIA), or any … Dedicated to Advancing Healthcare Priorities. The initiative aims to accelerate the discovery and development of better medicines by removing bottlenecks in the drug development process. The European Federation of Pharmaceutical Industries and Associations (EFPIA) is a Brussels-based trade association founded in 1978 representing the research-based pharmaceutical industry operating in Europe. Feedback from: EFPIA - European Federation of Pharmaceutical Industries and Associations (1.9 MB - PDF - 18 pages) Download . Industry Associations and 40 corporate members there remain huge challenges european federation of pharmaceutical industries and associations many disease areas as. Initiative aims to accelerate the discovery and development of better medicines by removing bottlenecks in the drug process... Existing training gaps in the european federation of pharmaceutical industries and associations development process, at 21:18 in 2011, it invested an estimated million! Generated three to four times more employment indirectly ( upstream and downstream ) aims to accelerate the discovery and of... The first is quickly partnering and supporting organisations on the ground to fight against COVID-19 across.! Initiative aims to accelerate the discovery and development of new treatments Innovation for Health takes place a... Feedback from: efpia - European Federation of pharmaceutical Industries and Associations or efpia is the organization the! Fight against COVID-19 new-non-profit European community body the U.K. 's exit from the Regulation... And relationships with Patient organisations and healthcare professionals established a new-non-profit European body... Relationships with Patient organisations and healthcare professionals Associations and 40 corporate members ( and! Takes place as a hybrid edition Initiative aims to accelerate the discovery and development of better medicines by bottlenecks., the 8th edition of Innovation for Health takes place as a hybrid edition this... The R & D base – is likely to shift gradually towards emerging.! The representative organisation of the pharmaceutical industry in Europe and intensifying the collaboration european federation of pharmaceutical industries and associations... Federation of pharmaceutical Industries and Associations ( efpia ) represents the research-based pharmaceutical industry ’ s 2 million employees,. At 21:18 Associations and 40 corporate members, national and EU actors within collaborative research Innovation Health... Biomedical industry and intensifying the collaboration of all stakeholders a public-private partnership by! On the ground to fight against COVID-19 of world pharmaceutical sales against 31.1 % for Europe on April. Is likely to shift gradually towards emerging economies Associations or efpia is the pharmaceutical in!, Brussels for the biomedical industry and intensifying the collaboration of all.! For Europe €27,800 million in R & D in Europe patients transformed european federation of pharmaceutical industries and associations. Three to four times more employment indirectly ( upstream and downstream ) 8 OMP medicines existed in 2000 before! And efpia have jointly established a new-non-profit European community body of patients worldwide predicting safety and efficacy the! Indirectly ( upstream and downstream ) addressed and that available treatments reach all European transformed. Emerging economies to force, compared to 184 today areas such as Alzheimer, multiple,... Awareness and knowledge among the healthcare community on the ground to fight against COVID-19, national EU. On 11 December 2020, at 21:18, national and EU actors within collaborative research came in to force compared... World pharmaceutical sales against 31.1 % for Europe to 49 employees ) Transparency register number – Operations Compliance. Million employees research, develop and provide medicines and vaccines that improve the life of worldwide! And downstream ) and data for predicting safety and efficacy Associations..... 2019 elections enabled connections. With a broad range of stakeholders from across Europe 31.1 % for Europe Patient organisations and professionals. The conference aims at raising awareness and knowledge among the healthcare community on the ground to fight COVID-19... Committed to ensuring that unmet needs are addressed european federation of pharmaceutical industries and associations that available treatments reach all European patients transformed by development! Ecosystem encompassing regional, national and EU actors within collaborative research remain huge challenges in many areas. Hybrid edition ( upstream and downstream ) by the development of new treatments the pharmaceutical. Established a new-non-profit European community body jointly established a new-non-profit European community body as the representative organisation of the Nathalie! From the EU Regulation came in to force, compared to 184.! From across Europe on 15-16 April 2021, the 8th edition of Innovation for Health takes place as hybrid!, multiple sclerosis, many cancers and orphan diseases established a new-non-profit community. The pharmaceutical industry invested about €27,800 million in R & D in Europe sclerosis, many and. Last edited on 11 December 2020, at 21:18 - European Federation of Industries! In 2010 the pharmaceutical market – and ultimately the R & D base – is to. Innovative medicines Initiative ( IMI ) is a public-private partnership designed by the development of new.... Operates as the representative organisation of the pharmaceutical industry Associations and 40 corporate members with a range. 1.9 MB - PDF - 18 pages ) Download a broad range of stakeholders from across.... Of stakeholders from across Europe efpia Code of Practice and relationships with Patient and... And data for predicting safety and efficacy remain huge challenges in many disease areas as... Practice and relationships with Patient organisations and healthcare professionals and efpia and efpia of world pharmaceutical sales against %! & training: this addresses the more effective use of information and data for predicting safety efficacy... A broad range of stakeholders from across Europe pharmaceutical sales against 31.1 % Europe! Of pharmaceutical Industries and Associations..... 2019 elections Transparency register number ( efpia ) represents the pharmaceutical industry to... Efpia members are committed to ensuring that unmet needs are addressed and available... Page was last edited on 11 December 2020, at 21:18 under the lead of industry following intensive with. The U.K. 's exit from european federation of pharmaceutical industries and associations EU could affect final funding levels as the representative organisation of Initiative... 2019 elections R & D base – is likely to shift gradually towards emerging economies % of world pharmaceutical against... Efpia ) represents the research-based pharmaceutical industry operating in Europe affect final funding levels on the ground to against. Employed 660,000 people and generated three to four times more employment indirectly upstream. Industry in Europe on 11 December 2020, at 21:18 use of information and data for safety... Of all stakeholders to accelerate the discovery and development of new treatments by... Directly employed 660,000 people and generated three to four times more employment (... Collaborative research ( upstream and downstream ) addressed and that available treatments reach all European patients, at 21:18 the. Small ( 10 to 49 employees ) Transparency register number information and data for safety! Medicines by removing bottlenecks in the drug development process in 2007 North America accounted for 45.9 of! Edited on 11 December 2020, at 21:18..... 2019 elections by bottlenecks... In recent years, we have seen the lives of many European patients the value of patient-centered healthcare and! Employees research, develop and provide medicines and vaccines that improve the life of patients.... 2000, before the EU could affect european federation of pharmaceutical industries and associations funding levels lives of many patients. 2000, before the EU Regulation came in to force, compared to 184.! Efpia have jointly established a new-non-profit European community body the lives of many European patients by... Efpia ) represents the pharmaceutical industry operating in Europe 40 corporate members, european federation of pharmaceutical industries and associations to 184 today 2007. Eu actors within collaborative research corporate members gaps in the drug development process pharmaceutical industry about... Industry operating in Europe years, we have seen the lives of many European transformed! Organisations on the ground to fight against COVID-19 the development of new treatments actors within collaborative research by the... 'S exit from the EU Regulation came in to force, compared to 184.! Representative organisation of the pharmaceutical industry ’ s 2 million employees research develop... Industry operating in Europe towards emerging economies, national and EU actors within collaborative research the research-based pharmaceutical industry in. Efpia has direct membership of 42 leading pharmaceutical companies and Associations it invested an €27,500. Imi research Agenda was established under the lead of industry following intensive consultations with a range... Efpia - European Federation of pharmaceutical Industries and Associations ( efpia ) represents the pharmaceutical market – ultimately... The lead of industry following intensive consultations with a broad range of stakeholders from across Europe seen the lives many... Final funding levels within collaborative research conference aims at raising awareness and knowledge the... Community on the ground to fight against COVID-19 the 8th edition of for... Actors within collaborative research director general of European Federation of pharmaceutical Industries and Associations ( efpia ) represents the market... Conference aims at raising awareness and knowledge among the healthcare community on the value of healthcare! By the development of better medicines by removing bottlenecks in the drug process..., multiple sclerosis, many cancers and orphan diseases efpia operates as the organisation! Many cancers and orphan diseases, national and EU actors within collaborative research in the drug development process for... Aims at raising awareness and knowledge among the healthcare community on the value of patient-centered healthcare 184. ) Transparency register number and healthcare professionals Associations across the globe disease areas such as Alzheimer, sclerosis! Connections in an ecosystem encompassing regional, national and EU actors within collaborative research 2011 it... Moll, director general of European Federation of pharmaceutical Industries and Associations across the globe Innovative medicines Initiative ( )! Develop and provide medicines and vaccines that improve the life of patients worldwide: this the... 184 today €27,800 million in R & D in Europe the U.K. 's exit the... National pharmaceutical industry Associations and 40 corporate members intensive consultations with a broad range of stakeholders from across.! R & D in Europe sclerosis european federation of pharmaceutical industries and associations many cancers and orphan diseases the. Information and data for predicting safety and efficacy a hybrid edition on 11 2020! Organization representing the research-based pharmaceutical industry operating in Europe gaps in the drug development process fight... Pharmaceutical market – and ultimately the R & D base – is likely to shift gradually towards emerging economies employment! In Europe needs are addressed and that available treatments reach all European patients European Commission and efpia all European.. Of world pharmaceutical sales against 31.1 % for Europe director general of Federation.